Evaluation of different tests based on observations for external model evaluation of population analyses
- PMID: 20033477
- PMCID: PMC2874574
- DOI: 10.1007/s10928-009-9143-7
Evaluation of different tests based on observations for external model evaluation of population analyses
Abstract
To evaluate by simulation the statistical properties of normalized prediction distribution errors (NPDE), prediction discrepancies (pd), standardized prediction errors (SPE), numerical predictive check (NPC) and decorrelated NPC (NPC(dec)) for the external evaluation of a population pharmacokinetic analysis, and to illustrate the use of NPDE for the evaluation of covariate models. We assume that a model M(B) has been built using a building dataset B, and that a separate validation dataset, V is available. Our null hypothesis H(0) is that the data in V can be described by M(B). We use several methods to test this hypothesis: NPDE, pd, SPE, NPC and NPC(dec). First, we evaluated by simulation the type I error under H(0) of different tests applied to the four methods. We also propose and evaluate a single global test combining normality, mean and variance tests applied to NPDE, pd and SPE. We perform tests on NPC and NPC(dec), after a decorrelation. M(B) was a one compartment model with first order absorption (without covariate), previously developed from two phase II and one phase III studies of the antidiabetic drug, gliclazide. We simulated 500 external datasets according to the design of a phase III study. Second, we investigated the application of NPDE to covariate models. We propose two approaches: the first approach uses correlation tests or mean comparisons to test the relationship between NPDE and covariates; the second evaluates NPDE split by category for discrete covariates or quantiles for continuous covariates. We generated several validation datasets under H(0) and under alternative assumptions with a model without covariate, with one continuous covariate (weight), or one categorical covariate (sex). We calculated the powers of the different tests using simulations, where the covariates of the phase III study were used. The simulations under H(0) show a high type I error for the different tests applied to SPE and an increased type I error for pd. The different tests present a type I error close to 5% for the global test appied to NPDE. We find a type I error higher than 5% for the test applied to classical NPC but this test becomes close to 5% for NPC(dec). For covariate models, when model and validation dataset are consistent, type I error of the tests are close to 5% for both effects. When validation datasets and models are not consistent, the tests detect the correlation between NPDE and the covariate. We recommend to use NPDE over SPE for external model evaluation, since they do not depend on an approximation of the model and have good statistical properties. NPDE represent a better approach than NPC, since in order to perform tests on NPC, a decorrelation step must be applied before. NPDE, in this illustration, is also a good tool to evaluate model with or without covariates.
Figures





Similar articles
-
Development and performance of npde for the evaluation of time-to-event models.Pharm Res. 2018 Jan 9;35(2):30. doi: 10.1007/s11095-017-2291-3. Pharm Res. 2018. PMID: 29368033
-
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.Pharm Res. 2006 Sep;23(9):2036-49. doi: 10.1007/s11095-006-9067-5. Epub 2006 Aug 12. Pharm Res. 2006. PMID: 16906454 Free PMC article.
-
Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):199-218. doi: 10.1007/s10928-020-09684-2. Epub 2020 Apr 22. J Pharmacokinet Pharmacodyn. 2020. PMID: 32323049 Free PMC article.
-
External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients.J Glob Antimicrob Resist. 2022 Sep;30:163-172. doi: 10.1016/j.jgar.2022.05.016. Epub 2022 May 28. J Glob Antimicrob Resist. 2022. PMID: 35640870
-
Developing Tools to Evaluate Non-linear Mixed Effect Models: 20 Years on the npde Adventure.AAPS J. 2021 May 19;23(4):75. doi: 10.1208/s12248-021-00597-7. AAPS J. 2021. PMID: 34009502 Review.
Cited by
-
Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis.Pharmaceutics. 2024 Jun 6;16(6):770. doi: 10.3390/pharmaceutics16060770. Pharmaceutics. 2024. PMID: 38931891 Free PMC article.
-
Development and performance of npde for the evaluation of time-to-event models.Pharm Res. 2018 Jan 9;35(2):30. doi: 10.1007/s11095-017-2291-3. Pharm Res. 2018. PMID: 29368033
-
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01352-17. doi: 10.1128/AAC.01352-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28893774 Free PMC article.
-
Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.Eur J Clin Pharmacol. 2018 Mar;74(3):297-305. doi: 10.1007/s00228-017-2386-0. Epub 2017 Dec 3. Eur J Clin Pharmacol. 2018. PMID: 29198064 Clinical Trial.
-
Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):499-518. doi: 10.1007/s10928-012-9264-2. Epub 2012 Aug 11. J Pharmacokinet Pharmacodyn. 2012. PMID: 22886041
References
-
- Powell JR, Gobburu JV. Pharmacometrics at FDA: evolution and impact on decisions. Clin Pharmacol Ther. 2007;82(1):97–102. Epub 2007 May 30. - PubMed
-
- Karlsson MO, Holford NH. A tutorial on visual predictive checks. 2008. p. 17. Abstr 1434 [ www.page-meeting.org/?abstract=1434]
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous